WHO ICTRP trial
A clinical trial to study the effects of 2 drug-mix (ciprofloxacin and…
CTRI/2022/02/040674 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2022/02/040674 |
|---|---|
| Public title | A clinical trial to study the effects of 2 drug-mix (ciprofloxacin and metronidazole) and calcium hydroxide-iodoform mix in children with infected primary molars |
| Scientific title | A prospective, blinded, randomized active-controlled clinical trial to evaluate the success of double antibiotic paste in pulpally infected primary molars |
| Primary sponsor | Dr Urvashi Sharma |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | India |
| Conditions | Health Condition 1: K04- Diseases of pulp and periapical tissues |
| Interventions | Intervention1: double antibiotic paste (ciprofloxacin and metronidazole): The double antibiotic paste in a concentration of 1mg/ml will be placed within the pulp chamber. The tooth will be sealed with glass ionomer cement. The patient will… |
| Registration date | Feb 28, 2022 |
| Target size | 40 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: